|
DE60023492T2
(de)
|
1999-05-17 |
2006-07-20 |
Novo Nordisk A/S |
Glucagon antagonisten/inverse agonisten
|
|
WO2000071518A2
(en)
|
1999-05-25 |
2000-11-30 |
Sepracor, Inc. |
Heterocyclic analgesic compounds and their use
|
|
US6511980B2
(en)
|
2000-05-05 |
2003-01-28 |
Ortho Mcneil Pharmaceutical, Inc. |
Substituted diamine derivatives useful as motilin antagonists
|
|
AU2001216218A1
(en)
|
2000-05-25 |
2001-12-11 |
Sepracor, Inc. |
Heterocyclic analgesic compounds and method of use thereof
|
|
US20040102431A1
(en)
|
2000-09-25 |
2004-05-27 |
Christoph Boss |
Substituted amino-aza-cycloalkanes useful against malaria
|
|
FR2815032B1
(fr)
|
2000-10-10 |
2003-08-08 |
Pf Medicament |
Nouveaux derives d'aminophenyle piperazine ou d'amino phenyle piperide inhibiteurs de proteines prenyl transferase ainsi que leurs preparations
|
|
FR2825706B1
(fr)
|
2001-06-06 |
2003-12-12 |
Pf Medicament |
Nouveaux derives de benzothienyle ou d'indole, leur preparation et leur utilisation comme inhibiteurs de proteines prenyl transferase
|
|
FR2839974B1
(fr)
|
2002-05-24 |
2004-07-16 |
Pf Medicament |
Derives de phenyl-furane ou de phenyl-thiophene,leur preparation et leur application a titre de medicament
|
|
WO2004009549A2
(en)
|
2002-07-18 |
2004-01-29 |
Actelion Pharmaceuticals Ltd |
Piperidines useful for the treatment of central nervous system disorders
|
|
WO2004026823A1
(en)
|
2002-09-20 |
2004-04-01 |
Pfizer Products Inc. |
Amide and sulfonamide ligands for the estrogen receptor
|
|
AU2003290796A1
(en)
|
2002-11-14 |
2004-06-15 |
The Scripps Research Institute |
Non-steroidal fxr agonists
|
|
US20050143449A1
(en)
|
2002-11-15 |
2005-06-30 |
The Salk Institute For Biological Studies |
Non-steroidal farnesoid X receptor modulators and methods for the use thereof
|
|
AU2003298654A1
(en)
|
2002-11-15 |
2004-06-15 |
The Salk Institute For Biological Studies |
Structure of the farnesoid x receptor ligand binding domain and methods of use therefor
|
|
GB0309781D0
(en)
|
2003-04-29 |
2003-06-04 |
Glaxo Group Ltd |
Compounds
|
|
US7754711B2
(en)
|
2003-07-30 |
2010-07-13 |
Xenon Pharmaceuticals Inc. |
Pyridazine derivatives and their use as therapeutic agents
|
|
PL1648874T3
(pl)
|
2003-07-30 |
2012-04-30 |
Xenon Pharmaceuticals Inc |
Pochodne piperazyny i ich zastosowanie jako środków leczniczych
|
|
US7759348B2
(en)
|
2003-07-30 |
2010-07-20 |
Xenon Pharmaceuticals Inc. |
Pyridazine derivatives and their use as therapeutic agents
|
|
WO2005058822A1
(en)
|
2003-12-17 |
2005-06-30 |
Actelion Pharmaceuticals Ltd |
Substituted amino-cycloalkanes
|
|
CN1914205A
(zh)
|
2003-12-19 |
2007-02-14 |
葛兰素集团有限公司 |
吡唑并[3,4－b]吡啶化合物及其作为磷酸二酯酶抑制剂的用途
|
|
EP1734970B1
(en)
|
2004-03-12 |
2014-12-31 |
Intercept Pharmaceuticals, Inc. |
Treatment of fibrosis using fxr ligands
|
|
JP2007530582A
(ja)
|
2004-03-26 |
2007-11-01 |
ライジェル ファーマシューティカルズ， インコーポレイテッド |
代謝可能部分を含む複素環抗ウイルス化合物およびその使用
|
|
WO2005113522A1
(en)
|
2004-05-07 |
2005-12-01 |
Janssen Pharmaceutica, N.V. |
Azole carboxamide inhibitors of bacterial type iii protein secretion systems
|
|
JP2006199656A
(ja)
|
2005-01-24 |
2006-08-03 |
Kowa Co |
アミド基を有する環状アミン化合物
|
|
MY144229A
(en)
|
2006-01-26 |
2011-08-15 |
Xenon Pharmaceuticals Inc |
Pyridazine derivatives and their use as therapeutic agents
|
|
JP2010517931A
(ja)
|
2006-02-14 |
2010-05-27 |
インターセプト ファーマシューティカルズ， インコーポレイテッド |
Ｆｘｒ媒介性の疾患または状態の予防または治療用のｆｘｒリガンドとしての胆汁酸誘導体
|
|
MX2008012404A
(es)
|
2006-03-28 |
2008-10-09 |
Novartis Ag |
Derivados de amida y su aplicacion para el tratamiento de enfermedades relacionadas con proteina-g.
|
|
US20080081824A1
(en)
|
2006-09-29 |
2008-04-03 |
Bristol-Myers Squibb Company |
Substituted piperidines as modulators of chemokine receptor activity
|
|
WO2008065500A2
(en)
|
2006-11-30 |
2008-06-05 |
Pfizer Products Inc. |
Heteroaryl amides as type i glycine transport inhibitors
|
|
CN101903351B
(zh)
|
2007-12-19 |
2014-09-10 |
贝林格尔.英格海姆国际有限公司 |
病毒聚合酶抑制剂
|
|
US20090270418A1
(en)
|
2008-01-09 |
2009-10-29 |
Marianne Sloss |
Pyrazole pyrazine amine compounds as kinase inhibitors, compositions thereof and methods of treatment therewith
|
|
US20100029657A1
(en)
|
2008-02-29 |
2010-02-04 |
Wyeth |
Bridged, Bicyclic Heterocyclic or Spiro Bicyclic Heterocyclic Derivatives of Pyrazolo[1, 5-A]Pyrimidines, Methods for Preparation and Uses Thereof
|
|
WO2010001869A1
(ja)
|
2008-06-30 |
2010-01-07 |
武田薬品工業株式会社 |
４置換ベンゼン化合物およびその用途
|
|
JP2010077109A
(ja)
|
2008-08-28 |
2010-04-08 |
Takeda Chem Ind Ltd |
複素環化合物およびその用途
|
|
JP2012516885A
(ja)
|
2009-02-04 |
2012-07-26 |
ファイザー・インク |
４−アミノ−７，８−ジヒドロピリド［４，３−ｄ］ピリミジン−５（６Ｈ）−オン誘導体
|
|
CN102471339A
(zh)
|
2009-07-15 |
2012-05-23 |
雅培制药有限公司 |
激酶的吡咯并吡啶抑制剂
|
|
JP2012532914A
(ja)
|
2009-07-15 |
2012-12-20 |
メルク セローノ ソシエテ アノニム |
テトラゾール誘導体
|
|
FR2963005B1
(fr)
|
2010-07-23 |
2012-08-17 |
Sanofi Aventis |
Derives d'oxadiazoles et de pyridazines, leur preparation et leur application en therapeutique
|
|
JP2014500319A
(ja)
|
2010-12-20 |
2014-01-09 |
アイアールエム・リミテッド・ライアビリティ・カンパニー |
ファルネソイドｘ受容体を調節するための組成物および方法
|
|
CN103502221B
(zh)
|
2011-03-18 |
2016-03-30 |
拜耳知识产权有限责任公司 |
N-(3-氨甲酰基苯基)-1h-吡唑-5-甲酰胺衍生物及其用于防治动物害虫的用途
|
|
SI2688403T1
(sl)
|
2011-03-23 |
2017-08-31 |
Trevena, Inc. |
Ligandi opioidnih receptorjev in metode uporabe in izdelave istega
|
|
EP2545964A1
(en)
|
2011-07-13 |
2013-01-16 |
Phenex Pharmaceuticals AG |
Novel FXR (NR1H4) binding and activity modulating compounds
|
|
US9492763B2
(en)
|
2011-07-13 |
2016-11-15 |
M. Technique Co., Ltd. |
Method for producing microparticles having controlled crystallite diameter
|
|
WO2013037482A1
(en)
|
2011-09-15 |
2013-03-21 |
Phenex Pharmaceuticals Ag |
Farnesoid x receptor agonists for cancer treatment and prevention
|
|
RU2543485C2
(ru)
|
2013-02-26 |
2015-03-10 |
Андрей Александрович Иващенко |
Гетероциклические агонисты рецепторов желчных кислот tgr5, фармацевтическая композиция, способы их получения и применения
|
|
SI3043865T1
(sl)
|
2013-09-11 |
2021-04-30 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Metode in farmacevtski sestavki za zdravljenje virusne okužbe s hepatitisom B
|
|
GB201316824D0
(en)
|
2013-09-23 |
2013-11-06 |
R & D Vernalis Ltd |
New Chemical Entities
|
|
US20150258052A1
(en)
|
2014-03-13 |
2015-09-17 |
Salk Institute For Biological Studies |
Methods of using fexaramine and agents that increase sympathetic nervous system activity to promote browning of white adipose tissue
|
|
EP3116878A4
(en)
|
2014-03-13 |
2018-02-14 |
Salk Institute for Biological Studies |
Fxr agonists and methods for making and using
|
|
US10077268B2
(en)
|
2014-03-13 |
2018-09-18 |
Salk Institute For Biological Studies |
FXR agonists and methods for making and using
|
|
AU2015229055B2
(en)
|
2014-03-13 |
2019-09-12 |
Salk Institute For Biological Studies |
Analogs of fexaramine and methods of making and using
|
|
US10301268B2
(en)
|
2014-03-13 |
2019-05-28 |
The Salk Institute For Biological Studies |
Analogs of fexaramine and methods of making and using
|
|
WO2016116054A1
(en)
|
2015-01-22 |
2016-07-28 |
Xiamen University |
Modulators of farnesoid x receptor and methods for the use thereof
|
|
JP2018510866A
(ja)
|
2015-03-13 |
2018-04-19 |
ソーク インスティテュート フォー バイオロジカル スタディーズ |
腸受容体を活性化させるための、ファルネソイドｘ受容体アゴニストでの、成体の潜在性自己免疫性糖尿病の治療
|
|
WO2017018751A1
(ko)
|
2015-07-24 |
2017-02-02 |
동국대학교 산학협력단 |
Blt 저해 활성을 갖는 신규 화합물 및 이를 유효성분으로 포함하는 염증성 질환 예방 또는 치료용 조성물
|
|
JP2018536016A
(ja)
|
2015-09-16 |
2018-12-06 |
メタクリン，インク． |
ファルネソイドｘ受容体アゴニストとその使用
|
|
EP3350166A4
(en)
|
2015-09-16 |
2019-05-01 |
Metacrine, Inc. |
FARNESOID-X RECEPTOR AGONISTS AND USES THEREOF
|
|
WO2017049173A1
(en)
|
2015-09-16 |
2017-03-23 |
Metacrine, Inc. |
Farnesoid x receptor agonists and uses thereof
|
|
EP3350158A4
(en)
|
2015-09-16 |
2019-05-08 |
Metacrine, Inc. |
Farnesoid x receptor agonists and uses thereof
|
|
CN108473484B
(zh)
|
2015-10-01 |
2021-06-29 |
弗门尼舍公司 |
可用作trpm8调节剂的化合物
|
|
CN105477636B
(zh)
|
2015-10-16 |
2019-09-17 |
厦门大学 |
使用阿维菌素及其衍生物治疗代谢疾病的方法
|
|
WO2017078928A1
(en)
|
2015-11-06 |
2017-05-11 |
Salk Institute For Biological Studies |
Fxr agonists and methods for making and using
|
|
CN107126419B
(zh)
|
2016-02-26 |
2020-06-19 |
石药集团中诺药业（石家庄）有限公司 |
一种奥贝胆酸片剂及其制备方法
|
|
WO2017170182A1
(ja)
|
2016-03-31 |
2017-10-05 |
株式会社Adeka |
感光性組成物及び新規化合物
|
|
WO2018170165A1
(en)
|
2017-03-15 |
2018-09-20 |
Metacrine, Inc. |
Farnesoid x receptor agonists and uses thereof
|
|
WO2018170167A1
(en)
|
2017-03-15 |
2018-09-20 |
Metacrine, Inc. |
Farnesoid x receptor agonists and uses thereof
|
|
WO2018170173A1
(en)
|
2017-03-15 |
2018-09-20 |
Metacrine, Inc. |
Farnesoid x receptor agonists and uses thereof
|
|
LT3609888T
(lt)
|
2017-03-15 |
2025-11-10 |
|
Farnezoidinio x receptoriaus agonistai ir jų panaudojimas
|
|
IL269068B
(en)
|
2017-03-15 |
2022-09-01 |
Metacrine Inc |
Paranoid x receptor agonists and uses thereof
|
|
CZ2017298A3
(cs)
|
2017-05-26 |
2018-12-05 |
Zentiva, K.S. |
Amorfní formy obeticholové kyseliny
|
|
WO2020060007A1
(ko)
|
2018-09-17 |
2020-03-26 |
엘지전자 주식회사 |
5g 이동통신에서 pdu 세션을 핸들링하는 방법 및 무선 기기
|
|
EA202190661A1
(ru)
|
2018-09-18 |
2021-08-13 |
Метакрайн, Инк. |
Агонисты фарнезоидного х-рецептора для лечения заболевания
|
|
US20220054469A1
(en)
|
2018-09-18 |
2022-02-24 |
Metacrine, Inc. |
Farnesoid x receptor agonists and uses thereof
|
|
CN113056271B
(zh)
|
2018-09-18 |
2024-10-29 |
奥加诺沃公司 |
法尼醇x受体激动剂及其用途
|
|
WO2020061116A1
(en)
|
2018-09-18 |
2020-03-26 |
Metacrine, Inc. |
Farnesoid x receptor agonists and uses thereof
|
|
MA53671A
(fr)
|
2018-09-18 |
2021-07-28 |
Metacrine Inc |
Formes cristallines d'un agoniste du récepteur farnésoïde x
|
|
WO2020061118A1
(en)
|
2018-09-18 |
2020-03-26 |
Metacrine, Inc. |
Farnesoid x receptor agonists and uses thereof
|
|
JP2022500393A
(ja)
|
2018-09-18 |
2022-01-04 |
メタクリン，インク． |
ファルネソイドｘ受容体アゴニストおよびその使用
|
|
IL296532A
(en)
|
2020-03-18 |
2022-11-01 |
Metacrine Inc |
Crystal forms of farnesoid x receptor agonist
|
|
CN120732854A
(zh)
|
2020-03-18 |
2025-10-03 |
伊莱利利公司 |
用于治疗疾病的法尼醇x受体激动剂
|
|
WO2021188695A1
(en)
|
2020-03-18 |
2021-09-23 |
Metacrine, Inc. |
Formulations of a farnesoid x receptor agonist
|